Maureen Metzger1, Mi-Kyung Song2, Sandra Ward3, Patricia Pat-Yue Chang4, Laura C Hanson4, Feng-Chang Lin5. 1. University of Virginia School of Nursing, USA. Electronic address: mjm9cd@virginia.edu. 2. Emory University Nell Hodgson School of Nursing, USA. 3. University of Wisconsin-Madison School of Nursing, USA. 4. University of North Carolina at Chapel Hill School of Medicine, USA. 5. University of North Carolina at Chapel Hill, USA.
Abstract
OBJECTIVES: To examine feasibility, acceptability and preliminary effects of an advance care planning (ACP) intervention, SPIRIT-HF, in LVAD patients and their surrogates. BACKGROUND:LVADs may improve HF symptoms but they are not curative. Thus, ACP is needed to prepare patients and surrogates for end-of-life (EOL) decision-making. METHODS: Bridge to transplant and destination therapyLVAD patient-surrogate dyads were randomized to either SPIRIT-HF or usual care. Percentages of eligible dyads who were enrolled and completed the study determined feasibility. Analysis of interviews with SPIRIT dyads determined acceptability. Group comparisons of dyad congruence, patient's decisional conflict, and surrogate's decision-making confidence determined preliminary effects. RESULTS:Of 38 eligible dyads, 29 (76%) were enrolled, randomized, and completed the study. The 14 intervention dyads characterized SPIRIT-HF as beneficial. All dyads demonstrated improvement in outcomes. However, SPIRIT-HF dyads tended toward greater congruence on patient EOL treatment goals. CONCLUSIONS: SPIRIT-HF is feasible and acceptable. Results will inform future trials.
RCT Entities:
OBJECTIVES: To examine feasibility, acceptability and preliminary effects of an advance care planning (ACP) intervention, SPIRIT-HF, in LVADpatients and their surrogates. BACKGROUND:LVADs may improve HF symptoms but they are not curative. Thus, ACP is needed to prepare patients and surrogates for end-of-life (EOL) decision-making. METHODS: Bridge to transplant and destination therapy LVADpatient-surrogate dyads were randomized to either SPIRIT-HF or usual care. Percentages of eligible dyads who were enrolled and completed the study determined feasibility. Analysis of interviews with SPIRIT dyads determined acceptability. Group comparisons of dyad congruence, patient's decisional conflict, and surrogate's decision-making confidence determined preliminary effects. RESULTS: Of 38 eligible dyads, 29 (76%) were enrolled, randomized, and completed the study. The 14 intervention dyads characterized SPIRIT-HF as beneficial. All dyads demonstrated improvement in outcomes. However, SPIRIT-HF dyads tended toward greater congruence on patient EOL treatment goals. CONCLUSIONS: SPIRIT-HF is feasible and acceptable. Results will inform future trials.
Authors: Soon J Park; Carmelo A Milano; Antone J Tatooles; Joseph G Rogers; Robert M Adamson; D Eric Steidley; Gregory A Ewald; Kartik S Sundareswaran; David J Farrar; Mark S Slaughter Journal: Circ Heart Fail Date: 2012-01-26 Impact factor: 8.790
Authors: James K Kirklin; David C Naftel; Francis D Pagani; Robert L Kormos; Lynne W Stevenson; Elizabeth D Blume; Marissa A Miller; J T Baldwin; J Timothy Baldwin; James B Young Journal: J Heart Lung Transplant Date: 2014-04-21 Impact factor: 10.247
Authors: David Feldman; Salpy V Pamboukian; Jeffrey J Teuteberg; Emma Birks; Katherine Lietz; Stephanie A Moore; Jeffrey A Morgan; Francisco Arabia; Mary E Bauman; Hoger W Buchholz; Mario Deng; Marc L Dickstein; Aly El-Banayosy; Tonya Elliot; Daniel J Goldstein; Kathleen L Grady; Kylie Jones; Katarzyna Hryniewicz; Ranjit John; Annemarie Kaan; Shimon Kusne; Matthias Loebe; M Patricia Massicotte; Nader Moazami; Paul Mohacsi; Martha Mooney; Thomas Nelson; Francis Pagani; William Perry; Evgenij V Potapov; J Eduardo Rame; Stuart D Russell; Erik N Sorensen; Benjamin Sun; Martin Strueber; Abeel A Mangi; Michael G Petty; Joseph Rogers Journal: J Heart Lung Transplant Date: 2013-02 Impact factor: 10.247
Authors: Keith M Swetz; Monica R Freeman; Omar F AbouEzzeddine; Kari A Carter; Barry A Boilson; Abigale L Ottenberg; Soon J Park; Paul S Mueller Journal: Mayo Clin Proc Date: 2011-06 Impact factor: 7.616
Authors: Mark S Slaughter; Joseph G Rogers; Carmelo A Milano; Stuart D Russell; John V Conte; David Feldman; Benjamin Sun; Antone J Tatooles; Reynolds M Delgado; James W Long; Thomas C Wozniak; Waqas Ghumman; David J Farrar; O Howard Frazier Journal: N Engl J Med Date: 2009-11-17 Impact factor: 91.245
Authors: Jody L Lin; Ellen A Lipstein; Eve Wittenberg; Djin Tay; Robert Lundstrom; Gari Lyn Lundstrom; Saadia Sediqzadah; Davene R Wright Journal: MDM Policy Pract Date: 2021-10-29